Physician-investor with a specialization in endocrinology (hormones + peptides), hypertension, and genomic medicine, I operate at the intersection of clinical medicine, venture capital, and technological innovation in precision and longevity medicine. I serve as Professor at the University of British Columbia and Faculty Lecturer at the Geneva College of Longevity Science, focusing on multi-omics, personalized medicine, and smart home health technologies.
As Managing Partner at FHS Capital, I’ve seeded and advised frontier health and deep tech startups including Flyby, The NU, Eli Health, Science & Humans, Supernatural, Jung+, AI Nexus, Geneseq Marketplace, and Healthspan Digital—ventures shaping the next era of accessible, AI-powered healthcare.
My mission is to build the infrastructure for longevity-focused care globally—integrating AI, multi-omics, and digital platforms to empower individuals in optimizing health and extending healthspan.